FELLOWSHIP PROGRAMS EVENTS
The USC Pharmaceutical Industry Fellowship Programs are designed to prepare postdoctoral scholars for rewarding careers in the pharmaceutical and biopharmaceutical industry. Fellows work with mentors and engage in training activities that enhance the skills required to excel in their field. Professional development support is a cornerstone of the fellowship, with opportunities for individualized goal setting, strengths identification and assessments, advising, coaching and mentoring.
Training opportunities for doctoral candidates include clinical development, drug delivery, health economics and outcomes research, medical and regulatory affairs, pharmacology, oncology, patient safety and more.
Upon completion of the program, fellows are well-prepared for the challenges of a career in the pharmaceutical industry. Alumni have gone on to secure impactful roles across industry, pharmacy practice, and research.
Learn more about USC Mann Fellowship Programs on Instagram.
Key Highlights
- Access to USC regulatory sciences, biopharmaceutical marketing and healthcare decision analysis courses and tuition remission, up to four units per semester towards a graduate certificate
- Networking with USC faculty, student fellows, and alumni
- Professional development support through individualized goal setting, strengths identification/assessments, advising, coaching, and mentoring opportunities
- Financial relocation assistance for fellows
- Financial support to attend professional conferences and events
- Possible teaching opportunities for APPE students
Available Fellowships
Please refer to the brochures below for details on the specific programs offered with our industry partners. Each fellowship provides unique opportunities for trainees to build specialized expertise for their chosen career path.
Fellowships are offered as one-year or two-year programs, beginning July 1 and ending June 30. While most programs follow this schedule, start and end dates are subject to change.
Accordion Content
- Clinical Development – Eye Care
- Drug Delivery Sciences
- Medical Affairs + Health Impact: Evidence Planning and Execution
- Medical Affairs + Health Impact: Eye Care
- Medical Affairs + Health Impact: Global Medical Information
- Medical Affairs + Health Impact: Global Scientific Publications
- Medical Affairs + Health Impact: Immunology — Dermatology
- Medical Affairs + Health Impact: Medical Compliance and Independent Education
- Medical Affairs + Health Impact: Medical Payer Strategy
- Medical Affairs + Health Impact: Medical Program Management
- Medical Affairs + Health Impact: Neuroscience – Parkinson’s Disease
- Medical Affairs + Health Impact: Neuroscience – Global Psychiatry Pipeline
- Medical Affairs + Health Impact: Neuroscience – Psychiatry
- Medical Affairs + Health Impact: Neuroscience, Eyecare, Specialty – Portfolio Strategy
- Medical Affairs + Health Impact: Oncology – Global External Scientific Collaborations
- Medical Affairs + Health Impact: Oncology – Portfolio Strategy & Communications
- Pharmacokinetic and Translational Science
- Retina Research Pharmacology
- US Oncology Marketing
- US Retina Marketing (no longer recruiting)
- Clinical Development – Oncology
- Scientific Communications & Medical Information
- Clinical Development
- Research Pharmacology
- Clinical Pharmacology
- Clinical Development – Oncology
- Development Operations – Business Strategy Leader (BSL)
- Global Medical Affairs – HIV Prevention & Treatment
- Global Medical Affairs – LIVE
- Global Medical Affairs – Oncology
- Global Regulatory Affairs – Virology
- Global Scientific Communications – Global Medical Information
- Global Scientific Communications – Global Scientific Publications (no longer recruiting)
- Patient Safety
- U.S. Medical Affairs – HIV Strategy & Scientific Collaboration
- U.S. Medical Affairs – Liver Strategy
- U.S. Medical Affairs – Patient Access and Quality of Care (PAQ) Strategy
- Medical Affairs
- Clinical Development
- Drug Safety & Pharmacovigilance
- Medical Communications
- Regulatory Advertising & Promotion
- Regulatory Affairs Strategy
- Global Health Economics and Outcomes Research (HEOR)
- Global Patient Safety
- Global Medical Information
- Global Medical Strategy
- Portfolio Management